Shortened LSD Intervention for Major Depressive Disorder
The purpose of this study is to determine the safety and clinical effectiveness of a shortened lysergic acid diethylamide (LSD) experience. This will be achieved by administering the drug risperidone 45-minutes after the administration of LSD.
- Status
- planned
- Phase
- Phase 1
- Institution
- Johns Hopkins University
- Principal investigator
- Sandeep Nayak, MD
- Start date
- 2026-08-31
- End date
- 2027-12-01
- Registry ID
- NCT07503002
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.